Furthermore, our recent clinical data demonstrated that a similar dendrimer conjugate was well tolerated with no significant long-term safety concerns, and led to reduced neuroinflammatory cytokine NfL, improved neurological biomarkers, and increased survival in patients with severe COVID-19 [61]. This evidence concerns the gene NEFL and COVID-19.